A stunning clinical trial has delivered results that doctors rarely see. Every single patient in the study saw their rectal ...

National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF ...

Despite a poor prognosis and resistance to chemotherapy, new targeted therapies based on genetic mutations are improving outcomes for patients with biliary tract cancer.

Prior systemic therapy for castration-sensitive prostate cancer will determine subsequent therapy used for mCRPC. Continue androgen-deprivation therapy for patients with mCRPC indefinitely. Early ...